[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2001250047A1 - Effector-specific protein assembly and uses thereof - Google Patents

Effector-specific protein assembly and uses thereof

Info

Publication number
AU2001250047A1
AU2001250047A1 AU2001250047A AU5004701A AU2001250047A1 AU 2001250047 A1 AU2001250047 A1 AU 2001250047A1 AU 2001250047 A AU2001250047 A AU 2001250047A AU 5004701 A AU5004701 A AU 5004701A AU 2001250047 A1 AU2001250047 A1 AU 2001250047A1
Authority
AU
Australia
Prior art keywords
effector
specific protein
protein assembly
assembly
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001250047A
Inventor
David Dudley Moore
Pavlos Pissios
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
Original Assignee
Baylor College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College of Medicine filed Critical Baylor College of Medicine
Publication of AU2001250047A1 publication Critical patent/AU2001250047A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70567Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/723Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/04Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU2001250047A 2000-03-24 2001-03-22 Effector-specific protein assembly and uses thereof Abandoned AU2001250047A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19194600P 2000-03-24 2000-03-24
US60191946 2000-03-24
PCT/US2001/040351 WO2001072969A1 (en) 2000-03-24 2001-03-22 Effector-specific protein assembly and uses thereof

Publications (1)

Publication Number Publication Date
AU2001250047A1 true AU2001250047A1 (en) 2001-10-08

Family

ID=22707573

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001250047A Abandoned AU2001250047A1 (en) 2000-03-24 2001-03-22 Effector-specific protein assembly and uses thereof

Country Status (3)

Country Link
US (1) US20020015966A1 (en)
AU (1) AU2001250047A1 (en)
WO (1) WO2001072969A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7044946B2 (en) * 2003-06-10 2006-05-16 Cryocath Technologies Inc. Surgical clamp having treatment elements
CN105866441B (en) * 2015-01-19 2017-07-28 中国科学院生态环境研究中心 A kind of method for detecting estrogen or oestrogen-like hormone compound concentration

Also Published As

Publication number Publication date
US20020015966A1 (en) 2002-02-07
WO2001072969A1 (en) 2001-10-04

Similar Documents

Publication Publication Date Title
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2001280471A1 (en) Novel secreted proteins and their uses
AU6058500A (en) Fusion protein and uses thereof
AU2002315388A1 (en) Novel phenylamino-pyrimidines and uses thereof
AU2002211717A1 (en) Stresscopins and their uses
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU4776800A (en) Acetylcholinesterase-derived peptides and uses thereof
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2002211220A1 (en) Secreted proteins and their uses
AU2002307031A1 (en) Thrombospondin-2 and uses thereof
AU2001274566A1 (en) Novel protein and dna thereof
AU2002312373A1 (en) Structural and cytoskeleton-associated proteins
AU2001290551A1 (en) Secreted proteins and their uses
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
AU2136401A (en) P450rai-2 and related proteins
AU2002236440A1 (en) Novel secreted proteins and their uses
AU2001244863A1 (en) Apoptin-associating protein
AU2001280993A1 (en) Tissue-associated proteins and their uses
AU2002239747A1 (en) Cystoskeleton-associated proteins
AU2001250047A1 (en) Effector-specific protein assembly and uses thereof
AU2001274563A1 (en) Novel polypeptide and its dna
AU2002240921A1 (en) Medane genes and proteins
AU2001278777A1 (en) Irap-binding protein
AU2001241044A1 (en) Mitf-associated proteins
AU2001234150A1 (en) Novel protein and gene encoding the same